AMERICAN ASSOCIATION FOR CANCER RESEARCH

Lobbying for AMERICAN ASSOCIATION FOR CANCER RESEARCH

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $100,000.00 expenses · posted Jul 17, 2026

Lobbying activity 4

Budget/Appropriations

FY 2027 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.

Medical/Disease Research/Clinical Labs

Cancer research generally Diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention

Tobacco

Tobacco control and prevention Tobacco cessation

Health Issues

Reducing cancer disparities Cancer survivorship

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.